Device Endotherapy

Single Use Biliary Balloon Dilator

Payments companies reported to CMS as associated with Single Use Biliary Balloon Dilator. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$281Kassociated payments (2023-2025)
120clinicians with associated payments
4companies reporting

By year

2024 $173K
2025 $107K

Payments reported as associated with Single Use Biliary Balloon Dilator, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neuroradiology $153K
Gastroenterology (Internal Medicine) $117K
Internal Medicine $1,840
Pediatric Gastroenterology $970
Family $908
Hospitalist $879

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Single Use Biliary Balloon Dilator

These are the largest totals companies reported as associated with Single Use Biliary Balloon Dilator. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Bradley Jabour Santa Monica, CA Neuroradiology $153,023.47
Muhammad Hasan Orlando, FL Gastroenterology (Internal Medicine) $48,509.10
Amy Hosmer Pittsburgh, PA Gastroenterology (Internal Medicine) $12,262.35
Koushik Das Saint Louis, MO Gastroenterology (Internal Medicine) $11,044.80
Simon Lo Los Angeles, CA Gastroenterology (Internal Medicine) $9,962.40
David Lichtenstein Philadelphia, PA Gastroenterology (Internal Medicine) $6,745.62
Kenneth Park West Hollywood, CA Gastroenterology (Internal Medicine) $6,600.00
Uzma Siddiqui Chicago, IL Gastroenterology (Internal Medicine) $4,757.00
Todd Baron Rochester, MN Gastroenterology (Internal Medicine) $1,411.50
Ryan Law Rochester, MN Gastroenterology (Internal Medicine) $1,340.00

Prescribed Single Use Biliary Balloon Dilator?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.